title: Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib.
authors.forename: Darren R
authors.initials: DR
authors.lastname: Feldman
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Martorella
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Robbins
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Motzer
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002292:Carcinoma, Renal Cell / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D007037:Hypothyroidism / Q000097:blood / Q000139:chemically induced*; D007211:Indoles / Q000008:administration & dosage / Q000009:adverse effects*; D007680:Kidney Neoplasms / Q000097:blood / Q000188:drug therapy*; D011758:Pyrroles / Q000008:administration & dosage / Q000009:adverse effects*; D000077210:Sunitinib; D013960:Thyroid Function Tests; D013963:Thyroid Hormones / Q000097:blood
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D013963:Thyroid Hormones; D000077210:Sunitinib